Affigen Competitors and Similar CompaniesClear all

Affigen's competitors and similar companies include Aravive, Takeda, Kyowa Kirin and 3sbio.
Affigen
Affigen
Affigen is a company that specializes in producing research and diagnostic reagents.
Aravive
Aravive
Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies.
Takeda
Takeda
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
Kyowa Kirin
Kyowa Kirin
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
3sbio
3sbio
3sbio (三生制药集团) is a company that develops biopharmaceuticals.
Founding Date
Founding Date
2016
Founding Date
2008
Founding Date
1781
Founding Date
2008
Founding Date
1993
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Houston, US HQ
Locations
Houston, US HQ
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Tokyo, JP HQ
Sydney, AU
Shanghai, CN
Prague, CZ
Tampere, FI
Düsseldorf, DE
Hong Kong, HK
see more
Locations
Shenyang, CN HQ
Employees
Employees
2
Employees
23
Employees
47,4554% decrease
Employees
5,669
Employees
5,577
Valuation ($)
Valuation ($)
N/A
Valuation ($)
2.9 m
Valuation ($)
43.7 b
Valuation ($)
8.8 b
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$9.1m (FY, 2022)
Revenue (est.)
¥4.6t (FY, 2025)
Revenue (est.)
¥496.8b (FY, 2025)
Revenue (est.)
¥17.7b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
¥818.8b (FY, 2025)
Cost of goods
¥114.3b (FY, 2025)
Cost of goods
¥818m (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
¥3.8t (FY, 2025)
Gross profit
¥383.4b (FY, 2025)
Gross profit
¥17b (FY, 2025)
Net income
Net income
N/A
Net income
($76.3m) (FY, 2022)
Net income
¥108.1b (FY, 2025)
Net income
¥67b (FY, 2025)
Net income
¥9.1b (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 17m
Total funding raised
N/A
Total funding raised
$ 57.8m
Total funding raised
N/A
Total funding raised
$ 15.2m
For sources of this data, please see the company profile

View Company Profiles

Aravive
HQ
Houston, US
Employees
23

Aravive is a clinical-stage biotechnology company developing therapies for solid tumors and hematologic malignancies.

View company
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease

Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.

View company
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,669

Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.

View company
3sbio
HQ
Shenyang, CN
Employees
5,577

3sbio (三生制药集团) is a company that develops biopharmaceuticals.

View company